✦ LIBER ✦

Outcome of treating advanced neuroendocrine tumours with radiolabelled somatostatin analogues

✍ Scribed by María Angustias Muros; Mariela Varsavsky; Pablo Iglesias Rozas; Javier Valdivia; Juan Ramón Delgado; Flavio Forrer; Lisa Bodei; Giovanni Paganelli

Book ID: 107596464
Publisher: Springer Milan
Year: 2009
Tongue: Spanish
Weight: 412 KB
Volume: 11
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-009-0310-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pre-therapeutic dosimetry with radiolabe

Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours

✍ F. Forrer; J. Mueller-Brand; H. Maecke 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 63 KB

Treatment of advanced endocrine gastroen

Treatment of advanced endocrine gastroenteropancreatic tumours using radiolabelled somatostatin analogues

✍ C. H. J. Van Eijck 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

Exceptional Results in Neuroendocrine-Me

Exceptional Results in Neuroendocrine-Metastases-Caused Paraplegia Treated with [90Y-DOTA]-d -Phe1-Tyr3-octreotide (90Y-DOTATOC), a Radiolabelled Somatostatin Analogue

✍ C. Waldherr; A. Haldemann; H.R. Maecke; A. Crazzolara; J. Mueller-Brand 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Somatostatin receptor expression, tumour

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

✍ Cebon, J 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 192 KB